about
Association of the mtDNA m.4171C>A/MT-ND1 mutation with both optic neuropathy and bilateral brainstem lesionsFree Mg2+ concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRSSyndromic parkinsonism and dementia associated with OPA1 missense mutationsDiffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's diseaseImaging brain functional and metabolic changes in restless legs syndrome.Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy.Diffusion-weighted imaging study of patients with essential tremor.Visual system involvement in patients with Friedreich's ataxia.Pitfalls and advantages of different strategies for the absolute quantification of N-acetyl aspartate, creatine and choline in white and grey matter by 1H-MRS.Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome.Secondary post-geniculate involvement in Leber's hereditary optic neuropathyFriedreich's ataxia: from disease mechanisms to therapeutic interventions.Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy.Energy metabolism in migraine.Cybrid studies establish the causal link between the mtDNA m.3890G>A/MT-ND1 mutation and optic atrophy with bilateral brainstem lesions.Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients.Magnetic resonance imaging and spectroscopy in the evaluation of neuromuscular disorders and fatigue.A combined a-EEG and MR spectroscopy study in term newborns with hypoxic-ischemic encephalopathy.'Behr syndrome' with OPA1 compound heterozygote mutations.Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy.Spinocerebellar ataxia type 12 identified in two Italian families may mimic sporadic ataxia.Cerebral functions and metabolism after antegrade selective cerebral perfusion in aortic arch surgery.Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.Abnormal brain energy metabolism shown by in vivo phosphorus magnetic resonance spectroscopy in patients with chronic liver disease.Impairment of brain and muscle energy metabolism detected by magnetic resonance spectroscopy in hereditary spastic paraparesis type 28 patients with DDHD1 mutations.Inflammatory mediators and cerebral embolism in carotid stenting: new markers of risk.Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging.Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle's disease.Assessment of glutamate and glutamine contribution to in vivo N-acetylaspartate quantification in human brain by (1)H-magnetic resonance spectroscopy.Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonus.Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease.Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy.Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy.Narcolepsy is a common phenotype in HSAN IE and ADCA-DN.Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1.The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.
P50
Q21093316-5DE80C01-D5A5-4709-9D34-3FC5F832C53EQ24814834-F40C0D39-E4A9-45B4-9B0B-F3D072D962ABQ28259640-33F209D5-4D57-4B15-921C-88BC784FCBF3Q28295298-B8225545-742B-433A-9853-1AA0018F030DQ30656967-913E4F27-4F9D-4E24-855F-E3FAE3E69D88Q30981396-59EB9C6B-C18B-455A-8584-5B14F5FED59FQ31110931-FD6753E8-193E-4667-A989-88A7B81A2791Q33377900-7CE086B1-6E35-4544-B241-CC70C77B88DDQ33463544-4FB923C0-7124-4381-A514-841F319BAFB0Q34489088-558C3ED1-19D1-4EF8-8711-A4FDD0E590A6Q34500034-5E4F10B8-E258-4484-B6CC-04E0DD3A1633Q34522239-72574482-7BB4-4EA8-8F9B-A9EEAF85F3E5Q35161341-14A6E5AC-782E-4968-B7A5-4F9EBA27B6E4Q36475097-F32D3A3E-7E55-46BE-A63B-380D9F2F576EQ37187580-DA25F3EF-5B54-4630-B72A-BDB3122949B0Q37381065-5F1F6570-A740-405C-A4DA-D22AD0504A10Q37969177-A7455089-0427-494D-81FD-B00924654E35Q38062687-F7D8E12D-6D38-4881-A7F1-3138ADF821F8Q39911281-3E837C1B-2DE4-47F5-A188-9E32C889443DQ42538852-84225FEA-0CF1-4604-BA0D-33CC7772F20DQ42579948-17B3EBB0-8465-4E94-9E7B-7B34A4296076Q42668081-1B767367-E2C9-4C87-B6E2-454FB31226E5Q43170409-9555205D-C510-4C51-B715-C9F6D76D2867Q43899144-0251833D-4648-42BF-9652-B25CC384991BQ44173979-4C1FE722-48BD-4765-973D-0BDC80D3675FQ44447343-A14D0F7B-8589-4DCA-8E62-F7BA5A994F3FQ44673162-B4719214-1D6E-4206-A0F0-EF834EF27AC3Q44698492-F861AFB1-248C-4C61-A8D7-812EAFAA1AA8Q45125308-0615139C-A594-4160-9AE4-082F097E43A3Q45201265-A0E23DBC-A8EF-48B2-82F2-33BE58BC2EC9Q45999781-49CE8944-80C4-4C90-9B7B-3AE17AAB8AE9Q46208219-0DC45EAD-FCB6-4A0D-AFF2-EEACFA628DB7Q46787328-232F8DEB-35ED-4F89-8155-3D54D32BB792Q46793891-B293A70A-24DA-4583-8E20-2472AE381F08Q46837332-908CD722-2990-40C9-9EE0-2E57BBB9241FQ47280933-A243F721-9218-48D2-8F8C-9C42ADF5D9F7Q47710646-8E3DBBFF-CCF6-49D3-B48D-5F8AD726598BQ48113682-30B20070-2BF6-4622-8A32-58BD4446C96BQ48114747-D4EA5764-1D00-43CB-84AA-192D731532A5Q48127788-B565BA46-39E4-4F2F-A67F-4D4158D6B7AD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Caterina Tonon
@ast
Caterina Tonon
@en
Caterina Tonon
@es
Caterina Tonon
@nl
type
label
Caterina Tonon
@ast
Caterina Tonon
@en
Caterina Tonon
@es
Caterina Tonon
@nl
altLabel
CATERINA TONON
@en
prefLabel
Caterina Tonon
@ast
Caterina Tonon
@en
Caterina Tonon
@es
Caterina Tonon
@nl
P106
P1153
6603945656
P21
P31
P496
0000-0002-0506-499X